Select a medication above to begin.
Eylea
aflibercept intravitreal
Adult Dosing .
Dosage forms: INJ (pre-filled syringe): 2 mg per 0.05 mL; INJ (vial): 2 mg per 0.05 mL
age-related macular degeneration, neovascular
- [2 mg intravitreally q8wk]
- Start: 2 mg intravitreally q4wk x3 doses; Info: may consider q12wk maint. dosing after 1y of tx; some pts may require q4wk maint. dosing
macular edema, retinal vein occlusion-associated
- [2 mg intravitreally q4wk]
diabetic macular edema
- [2 mg intravitreally q8wk]
- Start: 2 mg intravitreally q4wk x5 doses; Info: some pts may require q4wk maint. dosing
diabetic retinopathy
- [2 mg intravitreally q8wk]
- Start: 2 mg intravitreally q4wk x5 doses; Info: some pts may require q4wk maint. dosing
renal dosing
- [no adjustment]
- renal impairment: no adjustment
- HD/PD: no adjustment; no supplement
hepatic dosing
- [not defined]
Peds Dosing .
- Dosage forms: INJ (vial): 2 mg per 0.05 mL
retinopathy of prematurity
- [0.4 mg intravitreally x1]
- Info: if giving to both eyes, may admin. on same day; may repeat tx after at least 10 days
renal dosing
- [not defined]
- renal impairment: consider adult renal dosing for guidance
- HD/PD: consider adult renal dosing for guidance
hepatic dosing
- [not defined]